HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression

BACKGROUND: Long-term glycemic control reduces retinopathy risk, but transient worsening can occur with glucose control intensification. Glucagon-like peptide 1 receptor agonists (GLP-1RA) lower glucose, but the long-term impact on retinopathy is unknown. GLP-1RA cardiovascular outcome trials (CVOTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bethel, M. Angelyn, Diaz, Rafael, Castellana, Noelia, Bhattacharya, Indranil, Gerstein, Hertzel C., Lakshmanan, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783944/
https://www.ncbi.nlm.nih.gov/pubmed/33444163
http://dx.doi.org/10.2337/dc20-1815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783944/
https://www.ncbi.nlm.nih.gov/pubmed/33444163
http://dx.doi.org/10.2337/dc20-1815

Ejemplares similares